Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF785 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | SMIM24 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | TKTL2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | FHAD1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | MED7 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | NDUFB6 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | GAD1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | NDUFA6 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | RUNX3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |